The only side effect Ive experienced is a little acid reflux, but its mild and goes away quickly
Get a sneak peek into key market insights with our free sample report: The market is fueled by factors including increasing cases of type 2 diabetes and obesity, along with the combined advantages of these agonists in glycemic control and weight management
This can make you feel full for far longer than you would normally be after eating, and can lead to nausea and vomiting
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
Other studies show a similar impact on inflammatory markers independent of weight loss
Micro-habits involve encouraging consumers to take easy first steps that lead up to big results, says Noom CMO Peter Scherr